Multivitamin/mineral Supplements

Fact Sheet for Health Professionals

This is a fact sheet intended for health professionals. For a general overview, see our consumer fact sheet.


People in the United States have taken multivitamin/mineral (MVM) and multivitamin (MV) dietary supplements since the early 1940s, when the first such products became available [1]. MVMs, in particular, are popular supplements, currently taken by an estimated one-third of all adults in the United States, and one-quarter of children and adolescents take an MVM or MV [2,3]. MVMs and MVs accounted for 14% of all purchases of supplements and 38% of all sales of vitamin and mineral supplements in the United States in 2019 [4]. U.S. sales of all dietary supplements totaled an estimated $55.7 billion in 2020, including $21.2 billion for all supplements containing vitamins, minerals, or both, of which $8.0 billion was for MVMs and MVs [4].

MVM and MV supplements have no standard or regulatory definition, such as what nutrients they must contain or in what amounts. Therefore, these terms refer to products that have widely varying compositions [5]. These products go by various names, including multis and multiples, and manufacturers determine the combinations and levels of vitamins, minerals, and other ingredients in them.

Many types of MVMs, the focus of this fact sheet, are available in the marketplace. One way to group them is as follows (Table 1).

Table 1: Types of MVMs
Basic (broad spectrum) MVMs taken once a day that contain all or most vitamins and minerals, most in amounts that do not exceed the Daily Values (DVs), Recommended Dietary Allowances (RDAs), or Adequate Intakes (AIs) for these nutrients.* This fact sheet focuses primarily on these basic, broad-spectrum MVMs. Formulations for children, adult men and women, pregnant people, and older adults typically provide different amounts of the same vitamins and minerals to meet the needs of these populations.
High potency Some MVMs contain amounts of some vitamins and minerals that are substantially higher than the DV, RDA, AI, or even, in some cases, the established Tolerable Upper Intake Level (UL).** These MVMs might also include other nutrients and botanical ingredients. Manufacturers sometimes offer these MVMs in packs of two or more pills for users to take daily.
Specialized (condition specific) MVMs—such as those for energy, enhanced athletic performance, weight control, improved immune function, or eye health—often combine several vitamins and minerals with botanical and specialty ingredients, such as coenzyme Q10, probiotics, or glucosamine. Some of these products might contain amounts of nutrients that are substantially above the DV, RDA, AI, or even UL.
*The Food and Nutrition Board (FNB) at the National Academies of Sciences, Engineering, and Medicine establishes RDAs and AIs. RDAs are the average daily level of intake of essential nutrients sufficient to meet the requirements of nearly all (97–98%) healthy individuals. These values vary by age, sex, and nutrient. The FNB establishes AIs for nutrients when evidence is insufficient to develop an RDA; intakes at this level are assumed to ensure nutritional adequacy [6]. The U.S. Food and Drug Administration (FDA) develops DVs to help consumers compare the nutrient contents of foods and dietary supplements within the context of a total diet. The FDA establishes a single DV for each nutrient for adults and children from age 4 years, and the DV is usually one of the highest RDAs or AIs for that nutrient.
** ULs, which the FNB establishes for many nutrients, are the maximum daily intakes unlikely to cause adverse health effects. When intakes exceed the UL, the potential risk of adverse effects increases.

An additional complication for this product category is that many dietary supplements are not labeled as MVMs even though they contain a variety of vitamins and minerals [1]. For example, a manufacturer might label a product containing vitamins C and E, selenium, zinc, and beta-carotene as an antioxidant formula rather than an MVM.

Furthermore, investigators define MVMs differently (or sometimes not at all) in their studies to evaluate the potential health effects of these products. For example, the Agency for Healthcare Research and Quality, in an evidence-based review of the role of MVMs in chronic disease prevention, defined MVMs as products containing at least three vitamins and minerals in amounts below the UL but no herbs, hormones, or drugs [7]. One team of researchers categorized MVMs more ambiguously as stress-tab-type, therapeutic type, and one-a-day type, so these products probably included MVs as well [8]. Another team defined MVMs as full-spectrum products providing all 12 vitamins plus 10 minerals [9]. Some published reports of studies of dietary supplements use the generic term multivitamins to include products with and without minerals. Various government surveys of dietary supplements and popular food-frequency questionnaires also define MVs and MVMs differently, include different examples, or ask about different products.

Varying definitions of MVMs and the ability of manufacturers to change the composition of their products at will further complicate the study of MVMs' potential health impacts because different studies do not use products of similar composition. Whether studies find any benefits (or risks) of MVMs depends in large part on the combinations and amounts of nutrients in the MVMs used, and these studies' results are not generalizable to the enormous variety of MVMs available in the marketplace.

Extent of Multivitamin/mineral Use

An analysis of dietary supplement use in the United States from the 2017–2018 National Health and Nutrition Examination Survey (NHANES) found that MVMs (defined as products containing three or more vitamins and at least one mineral) were the most commonly consumed supplement. MVMs were taken in the past 30 days by 24.0% of men and women age 20–39 years, 29.8% of those age 40–59 years, and 39.4% of those age 60 and over [10]. Among children and adolescents, MVM use rates were 11.0% for up to 2 years of age, 34.6% for age 2–5 years, 29.5% for age 6–11 years, and 17.3% for age 12–19 years [11]. An earlier analysis of 2011–2014 NHANES data found that 31.2% of the U.S. adult population age 19 years and older reported taking an MVM in the past 30 days [2].

Overall, women are more likely (34.0%) to take an MVM than men (28.3%) [2]. Use rates by sex and age are 19.5% for men and 26.1% for women age 19–30 years, 25.1% for men and 33.0% for women age 31–50 years, 34.5% for men and 36.2% for women age 51–70 years, and 40.9% for men and 44.0% for women age 71 years and older.

MVM use is also more common among the children of women who take supplements; older adults; individuals with more education, a higher income, a healthier lifestyle and diet, and lower body-mass index (BMI); and residents of the western United States [1,2]. MVM use is less common among smokers and members of certain ethnic and racial groups, such as African Americans, Hispanics, and Native Americans, than among Whites.

Multivitamin/minerals and Health

People take MVMs for various reasons. This section summarizes the evidence on the use of MVMs to increase nutrient intakes and to improve health or prevent chronic disease.

Increase nutrient intakes

Taking an MVM increases nutrient intakes and helps people obtain recommended amounts of vitamins and minerals when they do not meet these needs from food alone [9,12].

The FNB notes that RDAs and AIs for nutrients are levels of intake to ingest, on average, each day from the diet [6]. The FNB does not address whether or to what extent nutrient supplements can compensate for dietary inadequacies. Nevertheless, some users consider use of an MVM as a form of dietary or nutritional insurance, a concept first introduced by Miles Laboratories to market its One-A-Day line of nutrient supplements in the 1940s [13].

MVMs can also increase the likelihood that users will have intakes of some nutrients that are higher than the ULs [14]. Excess nutrient intakes are even more likely among MVM users who also take single vitamin and mineral supplements [15].

Results from several studies demonstrate both the use of MVMs for nutritional insurance by some individuals and the potential of MVMs to lead to excessive intakes for others.

In one study, for example, investigators assessed the diets and use of MVMs in a large multiethnic cohort of 90,771 men and women age 45 and older from Los Angeles and Hawaii [16]. The investigators calculated nutrient intakes from participants' diets using a food frequency questionnaire and from MVMs (taken by 23%) using the nutrient composition of two commonly used MVMs. Approximately 74%–76% of the men and 72%–75% of the women had adequate intakes on average from food alone of the 17 nutrients examined, but use of MVMs increased the prevalence of adequacy to 84% for the men and 83% for the women. The greatest improvements in intake were for vitamins A and E and zinc. However, MVM users had excessive intakes of several nutrients; 10%–15% had excessive intakes of vitamin A, iron, and zinc, and 48%–61% had excessive intakes of niacin.

Several studies have found that MVM users tend to have higher micronutrient intakes from their diet alone than nonusers [15]. Ironically, the populations at highest risk of nutritional inadequacy who might benefit the most from MVMs are the least likely to take them [1]. Pregnant and breastfeeding people, adult women, non-Hispanic Blacks, people of low socioeconomic status, and individuals who are underweight or overweight are among the groups with the greatest risk of deficient intakes of one or more nutrients [9].

A cross-sectional analysis of a nationally representative sample of 1,003 pregnant U.S. people age 20 to 40 years from the 2001–2014 NHANES found that many consumed less than recommended amounts of many nutrients from diet alone [17]. Among the 69.8% who took a dietary supplement (most likely a prenatal MVM supplement), the risk of inadequate intakes of many nutrients was lower. For example, 27.7% had inadequate intakes of vitamin A from foods alone, but this rate dropped to 15.5% when supplements were included. However, supplement use increased the proportion of pregnant people with some intakes of iron (27.9%) and folic acid (33.4%) above the UL.

In Canada, almost all prenatal MVM supplements provide 1,000 mcg/day of folic acid. Therefore, the folic acid intakes of pregnant people who take these supplements and consume any foods fortified with this nutrient exceed the UL for this nutrient (1,000 mcg), even though many do not consume recommended amounts of folate from dietary sources alone [18]. Even in the United States, the amount of folic acid in prenatal MVM supplements is typically 800 or 1,000 mcg, which is much higher than the recommended amount (400 mcg) to reduce the risk of neural tube defects in babies [19].

Improve health or prevent chronic disease

Most studies of the potential value of MVMs to enhance health and prevent disease have been observational and compared individuals who chose to take MVM supplements with others who did not take supplements. Because people with healthier diets and lifestyles are more likely to use dietary supplements, attributing health benefits that are distinct from the benefits of healthy behaviors to the use of supplements is difficult [13]. Some studies have suggested potential health benefits or harms from the use of MVMs, but others have found none. Participants in these studies used a wide variety of MVMs containing different combinations and amounts of nutrients.

Clinical trials, where individuals are randomly assigned to take the dietary supplement or a placebo, are better than observational studies for determining whether MVMs might affect disease risk. However, few randomized controlled trials (RCTs) have been conducted because these studies need to be long enough to show effects on disease risk that go beyond simply identifying intermediate biomarkers that might suggest such risk. As with some observational studies, some RCTs have suggested that MVM use has potential health benefits, but others have found no such benefits. However, no two RCTs have used MVMs with the same combinations and amounts of nutrients.


Some experts have hypothesized that MVM use might reduce cancer risk or improve cancer outcomes, possibly because certain nutrients in MVMs might inhibit carcinogenesis or tumor progression. Studies of MVMs that have focused on cancer have been observational. They have examined associations between MVM use and overall cancer risk or risk of various types of cancer (including breast, prostate, and colon cancer) as well as associations with cancer-related death.

Evidence on the link between MVM use and cancer risk includes a meta-analysis of eight cohort and case-control studies published before August 2010 that evaluated the association between consumption of MVs and MVMs and breast cancer risk [20]. The studies (which were of low quality overall) included a total of 355,034 women age 20–79; those taking MVs and MVMs took them for at least 3 years. Even after using MVs and MVMs daily for at least 10 years, the women had the same risk of breast cancer as the nonusers. However, one study in this meta-analysis found a 19% higher risk of breast cancer in 25.5% of 35,329 Swedish women who reported taking an MV or MVM (in most cases nutrients in amounts close to RDA levels) than in women who did not take these supplements over an average of 9.5 years [21].

Another large prospective study investigated the association between use of MVs and MVMs (mostly MVMs described as therapeutic or theragran, one-a-day, or stress-tab) and risk of cancer by following 489,640 men and women age 50–71 years for 16 years [8]. Men and women who reported taking more than one MV or MVM daily at the beginning of the study had an 18% lower risk of developing colon cancer than nonusers. Men who took a daily MV or MVM had a 2% higher overall risk of cancer, including a 3% higher risk of prostate cancer, 8% higher risk of lung cancer, and a 16% higher risk of leukemia (which increased to 26% higher if they took more than one MV or MVM daily). Among women, taking a daily MV or MVM did not affect their overall risk of developing cancer except for oropharyngeal cancer, which increased by 46%. Women who took more than one MV or MVM daily had a 53% higher risk of oropharyngeal cancer but a 35% lower risk of leukemia. All results were adjusted to exclude potential confounders, such as the use of single vitamin or mineral supplements.

Studies on the association between MVM use and cancer-related deaths include one that followed 7,728 women in the Women's Health Initiative who had invasive breast cancer for an average of 7.1 years after their diagnosis [22]. At baseline, 37.8% reported taking an MVM (typically containing 20–30 vitamins and minerals). The rate of death from breast cancer (6.7% of the cohort) was 30% lower among the MVM users than nonusers. In addition, a study examined the association between daily MV or MVM use and colon cancer mortality over 16 years in 776,902 men and women, most of whom were White and middle-age or older [23]. During the study, 4,517 died of colon cancer. Use of MVs or MVMs (not further defined) was associated with an 11% lower risk of colon cancer mortality than among nonusers. However, use of MVs or MVMs conferred no protection among participants consuming less than two alcoholic beverages per day, whereas use among those consuming more was associated with a 29% lower risk of colon cancer mortality.

Cardiovascular disease

Some experts have hypothesized that MVM use might reduce the incidence of cardiovascular disease (CVD) or rates of deaths from this disease, possibly because certain nutrients in these products might reduce blood pressure or affect vascular function. Both observational studies and clinical trials have examined this possibility.

Observational studies

Studies that have examined associations of MVMs with CVD risk include the Physicians Health Study I. This study prospectively followed 18,530 male physicians age 40 years and older, of whom 20% reported taking an MV or MVM for an average of 12.2 years [24]. The results showed no significant associations between MV or MVM use and risk of major CVD events, including myocardial infarction (MI), stroke, and CVD death. However, the supplement users had a 14% lower risk of undergoing cardiac revascularization (coronary angioplasty or coronary artery bypass grafting). Furthermore, men who reported using MVs or MVMs for 20 years or more had a lower risk of major CVD events, stroke, ischemic heart disease, and cardiac revascularization than men who did not take MVs or MVMs.

Studies of the association between MVM use and CVD outcomes have focused on several outcomes, including cardiovascular events and mortality. For example, a 2018 meta-analysis of 16 prospective cohort studies (including the study described above and the two below) and two RCTs evaluated the association between use of MVMs (defined as containing more than three vitamins and minerals) and risk of various CVD outcomes, including coronary heart disease and stroke [25]. The studies included a total of 2,019,862 participants with a mean age of 57.8 years and had a mean duration of 11.6 years. Overall, MVM supplementation was not associated with better cardiovascular outcomes, including lower risk of mortality from CVD and coronary heart disease, or of stroke incidence and mortality.

Another study of CVD outcomes in MVM users matched use of MVMs (defined as products containing three or more vitamins and one or more minerals) and MVs among 8,678 adults from NHANES III (1988–1994) with mortality data reported through 2011 [26]. After adjustment for potentially confounding variables (e.g., age, race, BMI, serum lipids, and blood pressure), the use of MVMs for more than 3 years was associated with a substantial 44% reduction in CVD mortality rates among women but not men.

A third CVD outcomes study prospectively followed a cohort of 37,193 women age 45 and older (mean age 54 years) participating in the Women's Health Study who were users (38%) or nonusers (62%) of MVMs (including a wide range of lower-dose vitamins and minerals) for an average of 16.2 years. The study measured rates of major CVD events, including MI, stroke, and CVD death [27]. Neither baseline use nor changes in use of MVMs over time was associated with changes in the long-term risk of major CVD events, MI, stroke, cardiac revascularizations, or death from CVD.

Randomized controlled trials

RCTs have focused primarily on the link between MVM use and CVD (or all-cause mortality) outcomes. One RCT randomized 1,708 participants age 50 years and older who had had an MI at least 6 weeks earlier to take a daily MVM containing 27 nutrients (many in doses higher than recommended amounts) for a median of 31 months (range 13 to 60 months) or a placebo as well as their standard medications. The study's goal was to determine whether the supplement reduced the risk of additional cardiovascular events or death [28]. Participants receiving the supplement did not have significantly fewer cardiovascular events, but this finding should be interpreted with caution because many participants did not take the supplement or placebo as directed, and others withdrew from the study early.

A 2021 meta-analysis of nine RCTs (not including the study described above) evaluated the use of MVMs (defined as products that included most vitamins and minerals) by 22,773 individuals and a variety of CVD outcomes—including total CVD incidence and mortality, MI incidence and mortality, and stroke incidence and mortality—and all-cause mortality [29]. MVM use did not alter the risk of any of these outcomes.

Cataracts and age-related macular degeneration

Several epidemiological studies and small RCTs have suggested associations between higher intakes of antioxidants or zinc and reduced risk of age-related macular degneration (AMD), although not consistently [30].

In the Age-Related Eye Disease Study (AREDS), investigators randomized 4,757 individuals age 55–80 years who had varying degrees of AMD, cataract, or both conditions to receive a placebo or a daily supplement containing high doses of vitamin C (500 mg), vitamin E (400 International Units [IU]), beta-carotene (15 mg), zinc (80 mg), and copper (2 mg) [30,31]. Over an average follow-up period of 6.3 years, the supplements significantly reduced the risk of progression from intermediate to advanced AMD by 28% and reduced rates of loss of visual acuity by 27%. The supplements did not prevent AMD onset or affect cataract risk. A subsequent study, AREDS2, tested whether adding omega-3 fatty acids (containing 650 mg eicosapentaenoic acid [EPA] and 350 mg docosahexaenoic acid [DHA]) or lutein (10 mg) and zeaxanthin (2 mg) to the AREDS formula would make it more effective [32]. This study included 4,203 participants age 50–85 years who had intermediate AMD in both eyes or intermediate AMD in one eye and advanced AMD in the other eye. Adding omega-3 fatty acids, lutein and zeaxanthin, or both to the AREDS formulation did not further reduce the risk of progression to advanced AMD. However, the study showed that beta-carotene was not a required ingredient; the original AREDS formulation without beta-carotene provided the same protective effect on reducing the risk of advanced AMD as the AREDS2 formulation.

Pregnancy and birth outcomes

Dietary supplements are commonly taken during pregnancy to increase nutrient intakes, especially of key nutrients such as iron and folic acid. Some experts have hypothesized that MVM use might increase the chance of a healthy birth outcome.

A meta-analysis of 20 RCTs investigated whether supplementation with MVMs (whose composition varied by study but that contained multiple nutrients including iron and folic acid) by pregnant people led to better birth outcomes than use of supplements containing only iron with or without folic acid or, in one study, a placebo [33]. The trials included 141,849 pregnant people from low- or middle-income countries in Africa and Asia as well as in Mexico (where malnutrition and micronutrient deficiencies are not uncommon); only one of the studies was conducted in a high-income country, the United Kingdom. The use of MVMs resulted in lower odds of low birth weight (less than 2,500 g) by 12%, birth at a smaller size than normal for gestational age by 8%, and premature births (before week 37 of pregnancy) by 10% than use of supplements containing iron with or without folic acid alone or placebo. MVM supplementation did not have a beneficial or harmful effect on risk of stillbirths or of perinatal and neonatal mortality in comparison with iron and folic acid supplementation. The trial in the United Kingdom that compared an MVM to a placebo found no beneficial or harmful effect of the MVM on preterm births, birth at a smaller size than normal gestational age, or low birth weight.

A similar meta-analysis of 13 RCTs investigated whether use by pregnant adolescents and young adults age 10–19 years of an MVM (containing multiple nutrients) led to better birth outcomes than supplementation with only iron and folic acid [34]. The trials included a total of 15,283 pregnant adolescents and young adults from low- or middle-income countries in Africa and Asia. MVM supplementation resulted in 13% lower odds of low birth weight, 12% lower odds of preterm birth, and 14% lower odds of small size for gestational age than iron and folic acid supplementation alone.

Multiple outcomes

Several studies have evaluated the link between MVM use and many different health outcomes, including cancer, heart disease, osteoporosis, pulmonary diseases, psychiatric disorders, and mortality. Most have not found an effect of MVM use on any of the health outcomes measured.

Observational studies

One of the largest prospective studies of MVM use was the Women's Health Initiative, which evaluated the health of 161,808 postmenopausal women age 50–79 years and their risk factors for cancer, heart disease, and osteoporosis. A total of 41.5% of the women took an MVM (containing 20–30 vitamins and minerals in amounts not exceeding the RDAs), an MV (10 or more vitamins in amounts of 100% or more of the RDA), or a stress multisupplement (containing at least 10 nutrients, some in amounts more than twice the RDA) at least once a week. When the investigators compared the outcomes of supplement users and nonusers, they found no association between use of these products for a median of 8 years and an increased risk of any common cancer or total cancers, CVD, or total mortality [35]. Investigators who followed a multiethnic cohort of 182,099 men and women age 45–75 years living in Hawaii and California for an average 11 years found similar results [36]. Approximately 48% of the men and 52% of the women in this study reported taking an MV or MVM.

Other observational data on multiple outcomes come from a cross-sectional analysis of data from participants in the 2012 National Health Interview Survey. This analysis included 4,933 adults who reported taking an MV or MVM during the previous 12 months and 16,670 nonusers [37]. The supplement users reported better overall health than the nonusers, but the results showed no differences in various psychological, physical, or functional health outcomes [37]. Similarly, in a cohort study of 390,124 healthy U.S. adults (median age 61.5 years) who were followed for up to 27 years, those who reported using MVMs daily did not have a lower risk of mortality from all causes or from heart disease, cancer, or cerebrovascular disease than those who did not use MVMs [38].

Randomized controlled trials

Some evidence from RCTs has focused on the use of MVMs to reduce the risk of various chronic diseases. In 2006, researchers reviewed 63 published RCTs between 1966 and early 2006 that evaluated the potential impacts of MVs and MVMs and individual nutrient supplements on health and on the risk of certain medical conditions (cancer; age-related sensory loss; and cardiovascular, endocrine, neurologic, musculoskeletal, gastroenterologic, renal, and pulmonary diseases) [7]. Use of MVs and MVMs (products containing three or more vitamins and/or minerals in amounts below the ULs and no herbs) did not reduce the risk of any chronic disease. An expert panel that reviewed this report and participated in a state-of-the-science conference on the use of MVs and MVMs for chronic disease prevention at the National Institutes of Health in 2006 concluded that the evidence was insufficient for them to recommend for or against the use of MVs or MVMs to prevent chronic disease [1].

The Physicians Health Study II was the longest clinical trial to investigate whether MVMs might help prevent chronic disease. The study randomly assigned 14,641 male physicians in the United States age 50 and older to take a daily MVM (Centrum Silver) or placebo for a median of 11.2 years. Participants who took the MVM did not have fewer major cardiovascular events, myocardial infarctions, strokes, or cardiovascular-related deaths than nonusers [39]. MVM supplementation modestly but significantly reduced users' risk of developing cancer by 8% but did not reduce the risk of any type of cancer (e.g., of the prostate or colon) or overall cancer mortality [40]. The supplement also had no effect on cognitive decline with age [41]. In addition, the supplement reduced the risk of cataracts by 9% but did not help prevent AMD [42].

The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) was a subsequent clinical trial to investigate whether MVMs might help prevent cancer and CVD in both men and women [43]. This study randomly assigned 8,776 men age 60 years and older and 12,666 women age 65 years and older to take one of the following for a median of 3.6 years: a daily MVM (Centrum Silver, with small differences in ingredients and amounts from the supplement used in the Physicians Health Study II), a cocoa extract containing 500 mg of cocoa flavanols, both Centrum Silver and the cocoa extract, or both placebos. Participants who took the MVM supplement did not show a reduction in total invasive cancers but did have a 38% lower incidence of lung cancer. MVM supplementation did not reduce any cardiovascular events (such as heart attacks or strokes), death from CVD, or all-cause mortality.

An ancillary study to COSMOS, known as COSMOS-Mind, enrolled 2,262 of the older COSMOS participants (mean age 73 years) to investigate whether the cocoa extract, MVM, or both supplements might improve cognition compared with placebo over 3 years of daily use [44]. Participants completed standardized cognitive tests administered over the telephone at baseline and annually for 3 years. Participants who took the MVM supplement, with or without the cocoa extract, showed improved global cognition, which reflects overall ability across multiple cognitive domains, such as recall, recognition, and learning. The improvement was most pronounced in participants with a history of CVD. Participants who took the MVM also showed improved memory and executive function.

Similar findings were reported from COSMOS-Web, another ancillary study to COSMOS that included 3,562 participants (mean age 71 years) who completed computer-based cognitive assessments [45]. In this study, participants who took the MVM had significantly better memory at both 1 year and across 3 years of follow-up, on average, compared with those who took placebo. A third ancillary study, COSMOS-Clinic, included 573 participants (mean age 69 years) who completed in-person, detailed neuropsychological assessments at baseline and year 2 [46]. Compared with participants who took placebo, those who took the MVM showed an improvement in episodic memory over 2 years, but not executive function or attention. In addition, a meta-analysis of the three ancillary studies (COSMOS-Mind, Web, and Clinic) that included more than 5,000 participants showed that MVM use improved global cognition and episodic memory over time [46]. These findings suggest that MVM supplementation can help maintain or enhance cognitive function in older adults.

Other RCTs have evaluated the effects of MVMs on outcomes in individuals with a range of chronic diseases. One RCT conducted in Linxian, China, randomized 3,318 persons age 40–69 years who had precancerous lesions in the esophagus (a relatively common condition in this population, which had a low dietary intake of several nutrients) to receive a daily MVM containing 14 vitamins and 12 minerals in doses two to three times recommended amounts or a placebo for 6 years [47]. The supplement did not reduce incidence or mortality rates for esophageal cancer or the rate of mortality from any cause. After the investigators followed participants for up to 20 additional years, when participants were no longer taking the study supplement, the use of the MVMs during the RCT did not result in lower rates of total mortality or mortality from any cause of death examined, including cancer, heart disease, and stroke [48].

One meta-analysis of 21 RCTs investigated whether daily use of MVs and MVMs (products containing three or more nutrients) for at least 1 year affected mortality risk [49]. The studies included a total of 91,074 healthy adults (average age 62 years) taking the MVs or MVMs for an average of 43 months, and the investigators reported 8,794 deaths. The products provided an average of 14 nutrients, although the products with three nutrients in five trials did not contain a mineral. The use of MVs or MVMs had no effect on all-cause mortality or on mortality due to CVD or cancer.

A review of 16 RCTs of MVs and MVMs (containing more than four nutrients including, in most cases, at least one mineral) in 1,719 participants who had at least one of six types of psychiatric symptoms (depression, post-disaster stress, antisocial behavior, behavioral deficits in dementia, attention-deficit/hyperactivity disorder, or autism) found that the supplements provided no clear reduction in symptoms [50]. However, the quality of the studies was generally poor, most had small samples (as few as 20 participants), and they used different MVs and MVMs and outcome measures.

One well-known trial of the impact of MVMs on both chronic disease risk and mortality used combinations of antioxidant nutrients. In the French Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI.MAX) study, investigators randomly assigned 13,017 adults age 35–60 years to receive a placebo or a daily supplement containing moderate amounts of vitamin C (120 mg), vitamin E (30 mg), beta-carotene (6 mg), selenium (100 mcg), and zinc (20 mg) [51]. After 7.5 years of use, the supplements lowered total cancer incidence by 31% and all-cause mortality rates by 37% in men but not women. The supplements provided no protection from CVD.

Multivitamins/minerals and Use of Supplements Containing Individual Nutrients Found in Multivitamins/minerals

Overall, MVMs do not appear to reliably reduce the risk of chronic diseases when people choose to take these products for up to a decade (or more) or when studies randomize people to take them as part of a clinical trial. An evidence review commissioned by the U.S. Preventive Services Task Force (USPSTF) included 78 RCTs with 324,837 participants and six cohort studies with 390,689 participants [52]. It concluded that vitamin and mineral supplements had little or no benefit in preventing cancer, CVD, and death, except that MVMs may provide a small benefit against cancer. Based on this review, the USPSTF concluded there was insufficient evidence to determine the balance of benefits and harms in taking MVMs to prevent CVD or cancer [53]. The American Institute for Cancer Research recommends against taking dietary supplements for cancer prevention because supplements do not provide the same benefits as eating whole foods [54]. Similarly, the American Heart Association advises against the use of MVMs to prevent CVD because scientific studies have found them to be of no value for this purpose [55].

Although MVM use might not reduce overall chronic disease risk, these supplements or several nutrients they contain might benefit certain groups of people. Examples of these populations are described below.

People who could become pregnant

The Centers for Disease Control and Prevention (CDC) recommends that people capable of becoming pregnant consume 400 mcg/day of folic acid from fortified foods, dietary supplements, or both [6,56]. Obtaining sufficient amounts of folic acid in the periconceptual period reduces the risk of neural tube defects in newborns. The Dietary Guidelines for Americans 2020–2025 (DGA) notes that the critical period for folic acid supplementation to prevent neural tube defects starts at least 1 month before conception and continues through the first 2 to 3 months of pregnancy [57]. The USPSTF advises people who are planning to become or capable of becoming pregnant to take a dietary supplement providing 400 to 800 mcg/day of folic acid daily [58].

Pregnant people

The American College of Obstetricians and Gynecologists recommends that pregnant people take a daily prenatal vitamin [59]. Acknowledging that most health care providers recommend that pregnant people take a daily prenatal MVM, the DGA states that this practice may be necessary to meet the needs for folate or folic acid, iron, iodine, and vitamin D during pregnancy [57]. The DGA also states that pregnant people might need to take separate supplements of iodine and choline when their health care provider recommends that they do so because many prenatal MVMs do not contain these nutrients or contain only small amounts. The report recommends that people following a vegetarian or vegan diet consult their health care provider about whether they need supplementation with iron, vitamin B12, and other nutrients (e.g., choline, iodine, EPA, and DHA). The World Health Organization recommends iron and folic acid supplementation throughout pregnancy [60].

Infants and children

Because breastmilk provides little vitamin D, the American Academy of Pediatrics recommends that exclusively and partially breastfed infants receive supplements of 400 IU (10 mcg)/day of vitamin D beginning in the first few days after birth and continued until the infant is weaned and drinks at least 1 liter or 1 quart of vitamin D-fortified formula or whole milk daily [61]. The academy also recommends that non-breastfed infants and older children who consume less than 1 liter of vitamin D-fortified formula or milk receive 400 IU (10 mcg) supplemental vitamin D daily. The FNB and DGA agree that fully and partially breastfed infants should receive a supplement containing approximately 400 IU (10 mcg)/day vitamin D beginning in the first week of life [57,62]. The American Academy of Pediatrics adds that all non-breastfed infants ingesting less than 1,000 mL/day of vitamin D–fortified formula or milk should receive a supplement containing 400 IU (10 mcg)/day vitamin D [61]. The DGA, noting the difficulty of obtaining sufficient vitamin D from foods, advises that young children might need to continue taking a vitamin D supplement after age 12 months [57]. The DGA adds that infants fed human milk might also require a vitamin B12 supplement if the mother’s vitamin B12 status is inadequate, which might occur, for example, if she follows a vegan diet [57].

Adults age 50 and older

The FNB advises people older than 50 years to obtain recommended amounts of vitamin B12, mainly from fortified foods or dietary supplements. Adults in this age group might not be able to absorb enough of the protein-bound, naturally occurring vitamin B12 in food because gastric acidity tends to decline and atrophic gastritis tends to become more common with age [6]. The DGA also recommends obtaining recommended amounts of vitamin B12 primarily from fortified foods or dietary supplements, but only for people age 60 and older. The DGA adds that the use of some medications (such as proton pump inhibitors) can decrease absorption of vitamin B12 in foods [57].

Findings from three ancillary studies to the COSMOS clinical trial that included more than 5,000 older adults (mean age 69 to 73 years) suggest that taking an MVM for 1 to 3 years can help maintain or enhance cognitive function [46].


Individuals who have poor nutrient intakes from diet alone, consume low-calorie diets, or avoid certain foods (such as strict vegetarians and vegans) might benefit from taking an MVM [63]. Health care providers sometimes prescribe MVMs for people who have medical conditions and diseases that impair digestion, absorption, or use of nutrients.

No U.S. government health agency, private health group, or health professional organization promotes regular use of MVMs. In general, MVMs might help people who do not eat a variety of nutritious foods to obtain adequate amounts of essential nutrients. However, MVMs cannot take the place of the variety of foods that are important to a healthy diet, because foods provide other nutrients and components that have benefits for health.

Safety Issues

Taking a basic MVM that provides nutrients in amounts that are approximately the same as recommended intakes should be safe for healthy people. Studies of MVM users reveal no adverse effects, except that both treatment and placebo groups in some studies experienced some minor gastrointestinal issues [64]. However, individuals who take MVMs and other supplements and who consume fortified foods and beverages might obtain some nutrients in amounts exceeding the UL, increasing the possibility of adverse effects [65]. Excess intakes can also be a concern for people taking MVMs that contain some vitamins or minerals in amounts approaching or exceeding the UL.

Smokers and, possibly, former smokers should avoid MVM products providing large amounts of beta-carotene or vitamin A because two studies have linked these nutrients to an increased risk of lung cancer in smokers [66]. In one RCT of 29,133 male Finnish smokers, those who took supplemental beta-carotene (20 mg/day), with or without vitamin E (50 mg/day as dl-alpha tocopheryl acetate), had an 18% higher incidence of lung cancer during 5–8 years of follow-up than smokers who took a placebo or vitamin E [67]. In another RCT of 18,314, smokers, former smokers, and asbestos-exposed persons, participants who took a combination of 30 mg/day of beta-carotene plus 25,000 IU/day of vitamin A (as retinol) had a 28% higher lung cancer risk than those taking a placebo after an average 4-year follow-up period [68]. Based on these two trials, the USPSTF warned that beta-carotene supplementation may increase the risk of lung cancer in people who smoke, have smoked, or have occupational exposure to asbestos [53]. The USPSTF also noted that beta-carotene supplementation may increase the risk of mortality from CVD.

Taking excess vitamin A (as retinol or other preformed forms of vitamin A but not beta-carotene) during pregnancy can increase the risk of birth defects in infants. The UL for vitamin A during pregnancy is 2,800 mcg/day for adolescents and 3,000 mcg/day for women [69].

Interactions with Medications

MVMs providing nutrients in recommended amounts do not ordinarily interact with medications, with one important exception. People who take certain blood thinners, such as warfarin (Coumadin, Jantoven), should talk with their health care providers before taking any MVM or dietary supplement containing vitamin K [70,71]. Vitamin K is involved in blood clotting and decreases the effectiveness of warfarin and similar drugs. Health care providers determine the dose of this medication for a given patient in part by assessing the amount of vitamin K that the patient routinely consumes.

Choosing a Multivitamin/mineral

Basic MVMs contain both vitamins and minerals, most in amounts that do not exceed the DVs. However, MVMs often have small amounts of certain nutrients, such as calcium, magnesium, and potassium, so supplement users should check product labels. When choosing an MVM product, consumers should consider taking a product designed for people of their age, sex, and life stage (e.g., pregnancy). MVMs for older adults (sometimes called senior or 50+ formulations), for example, often contain little or no iron and more calcium, vitamin D, and vitamin B12 than MVMs for younger adults [72]. Prenatal supplements generally provide no vitamin A in the form of retinol, and most children’s MVMs provide age-appropriate amounts of nutrients.

Multivitamins/minerals and Healthful Diets

According to the federal government’s 2020–2025 DGA, "Because foods provide an array of nutrients and other components that have benefits for health, nutritional needs should be met primarily through foods. ... In some cases, fortified foods and dietary supplements are useful when it is not possible otherwise to meet needs for one or more nutrients (e.g., during specific life stages such as pregnancy" [57].

The DGA does not mention MVMs, but it does recommend that Americans choose healthy, nutrient-dense food and beverages. The DGA lists nutrients of special public health concern in American diets, such as calcium, potassium, dietary fiber, and vitamin D in both adults and children. Iron is also a nutrient of public health concern for infants age 6–11 months who are fed primarily human milk and do not consume enough iron from complementary foods, adolescent females, and people who are pregnant. Depending on their formulations, MVMs can help individuals obtain adequate amounts of these nutrients, except for potassium (because MVMs contain only very small amounts of this mineral) and dietary fiber.

For more information about building a healthy dietary pattern refer to the Dietary Guidelines for Americansexternal link disclaimer and the U.S. Department of Agriculture's MyPlateexternal link disclaimer.


  1. NIH State-of-the-Science Panel. National Institutes of Health state-of-the-science conference statement: multivitamin/mineral supplements and chronic disease prevention. Am J Clin Nutr 2007;85:257S-264S. [PubMed abstract]
  2. Cowan AE, Jun S, Gahche JJ, Tooze JA, Dwyer JT, Eicher-Miller HA, et al. Dietary supplement use differs by socioeconomic and health-related characteristics among U.S. adults, NHANES 2011-2014. Nutrients 2018;10(8). [PubMed abstract]
  3. Qato DM, Alexander GC, Guadamuz JS, Lindau ST. Prevalence of dietary supplement use in US children and adolescents, 2003-2014. JAMA Pediatr 2018;172:780-2. [PubMed abstract]
  4. Nutrition Business Journal. Supplement Business Report 2021. Boulder, CO: New Hope Network, 2021.
  5. Yetley, EA. Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions. Am J Clin Nutr 2007;85:269S-276S. [PubMed abstract]
  6. Otten JJ, Hellwig JP, Meyers LD (editors). Dietary Reference Intakes: The Essential Guide to Nutrient Requirementsexternal link disclaimer. Washington, DC: The National Academies Press. 2006.
  7. Huang H-Y, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer C, et al. Multivitamin/Mineral Supplements and Prevention of Chronic Disease. Evidence Report/Technology Assessment No. 139. (Prepared by The Johns Hopkins University Evidence-based Practice Center under Contract No. 290-02-0018). AHRQ Publication No. 06-E012. Rockville, MD: Agency for Healthcare Research and Quality. May 2006.
  8. Lim J, Weinstein SJ, Liao LM, Sinha R, Huang J, Albanes D. Multivitamin use and overall and site-specific cancer risks in the National Institutes of Health-AARP Diet and Health Study. J Nutr, 2021. Published online ahead of print. [PubMed abstract]
  9. Bird JK, Murphy RA, Ciappio ED, McBurney MI. Risk of deficiency in multiple concurrent micronutrients in children and adults in the United States. Nutrients 2017; 9: 655. [PubMed abstract]
  10. Mishra S, Stierman B, Gahche JJ, Potischman N. Dietary supplement use among adults: United States, 2017-2018external link disclaimer. NCHS Data Brief, No 399. Hyattsville, MD: National Center for Health Statistics. February 2021.
  11. Stierman B, Mishra S, Gahche JJ, Potischman N, Hales CM. Dietary supplement use in children and adolescents aged <19 years—United States, 2017-2018. MMWR 2020;69:1557-62. [PubMed abstract]
  12. Blumberg JB, Bailey RL, Sesso HD, Ulrich CM. The evolving role of multivitamin/multimineral supplement use among adults in the age of personalized nutrition. Nutrients 2018, 10, 248.
  13. Rosenberg IH. Challenges and opportunities in the translation of the science of vitamins. Am J Clin Nutr 2007;85:325S-7S. [PubMed abstract]
  14. Blumberg JB, Frei BB, Fulgoni III VL, Weaver CM, Zeisel SH. Impact of frequency of multi-vitamin/multi-mineral supplement intake on nutritional adequacy and nutrient deficiencies in U.S. adults. Nutrients 2017, 9, 849. [PubMed abstract]
  15. Rock CL. Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr 2007;85:277S-9S. [PubMed abstract]
  16. Murphy SP, White KK, Park S-Y, Sharma S. Multivitamin-multimineral supplements' effect on total nutrient intake. Am J Clin Nutr 2007;85:280S-4S. [PubMed abstract]
  17. Bailey RL, Pac SG, Fulgoni III VL, Reidy KC, Catalano PM. Estimation of total usual dietary intakes of pregnant women in the United States. JAMA Network open 2019;2(6):e195967. [PubMed abstract]
  18. Rose EG, Murphy MSQ, Erwin E, Muldoon KA, Harvey ALJ, White RR, et al. Gestational folate and folic acid intake among women in Canada at higher risk of pre-eclampsia. J Nutr 2021;151:1976-82. [PubMed abstract]
  19. Saldanha LG, Dwyer JT, Haggans CJ, Mills JL, Potischman N. Perspective: Time to resolve confusion on folate amounts, units, and forms in prenatal supplements. Adv Nutr 2020;11:753-9. [PubMed abstract]
  20. Chan ALF, Leung HWC, Wang S-F. Multivitamin supplement use and risk of breast cancer: A meta-analysis. Ann Pharmacother 2011;45:476-84. [PubMed abstract]
  21. Larsson SC, Åkesson A, Bergkvist L, Wolk A. Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women. Am J Clin Nutr 2010;91:1268-1272. [PubMed abstract]
  22. Wassertheil-Smoller S, McGinn AP, Budrys N, Chlebowski R, Ho GY, Johnson KC, et al. Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women's health initiative. Breast Cancer Res Treat 2013;141:495-505. [PubMed abstract]
  23. Jacobs EA, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, et al. Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes and Control 2001;12:927-34. [PubMed abstract]
  24. Rautiainen S, Rist PM, Glynn RJ, Buring JE, Gaziano JM,Sesso HD. Multivitamin use and the risk of cardiovascular disease in men. J Nutr 2016;146:1235-40. [PubMed abstract]
  25. Kim J, Choi J, Kwon SY, McEvoy JW, Blaha MJ, Blumenthal RS, et al. Association of multivitamin and mineral supplementation and risk of cardiovascular disease. Circ Cardiovasc Qual Outcomes 2018; 11(7):e004224. [PubMed abstract]
  26. Bailey RL, Fakhouri TH, Park Y, Dwyer JT, Thomas PR, Gahche JJ, et al. Multivitamin-mineral use is associated with reduced risk of cardiovascular disease mortality among women in the United States. J Nutr 2015;572-8. [PubMed abstract]
  27. Rautiainen S, Lee I-M, Rist PM, Gaziano JM, Manson JE, Buring JE, Sesso HD. Multivitamin use and cardiovascular disease in a prospective study of women. Am J Clin Nutr 2015;101:144-52. [PubMed abstract]
  28. Lamas GA, Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, et al. Oral high-dose multivitamins and minerals after myocardial infarction. A randomized trial. Ann Intern Med 2013;159:797-805. [PubMed abstract]
  29. Jenkins DJA, Spence JD, Giovannucci EL, Kim Y-I, Josse RG, Vieth R, et al. Supplemental vitamins and minerals for cardiovascular disease prevention and treatment. J Am Coll Cardiol 2021;77:423-36. [PubMed abstract]
  30. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36. [PubMed abstract]
  31. NEI (National Eye Institute). AREDS/AREDS2 clinical trials. 2020.
  32. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005-15. [PubMed abstract]
  33. Keats EC, Haider BA, Tam E, Bhutta ZA. Multiple-micronutrient supplement for women during pregnancy (review). Cochrane Database of Systematic Reviews 2019, Issue 3. Art. No.: CD004905. [PubMed abstract]
  34. Keats EC, Akseer N, Thurairajah P, Cousens S, Bhutta ZA, the Global Young Women's Nutrition Investigators' Group. Multiple-micronutrient supplementation in pregnant adolescnts in low- and middle-income countries: A systematic review and meta-analysis of individual participant data. Nutrition Reviews 2021; published online ahead of print. [PubMed abstract]
  35. Neuhouser ML, Wassertheil-Smoller S, Thomson C, Aragaki A, Anderson GL, Manson JE, et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med 2009;169:294-304. [PubMed abstract]
  36. Park S-Y, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Multivitamin use and the risk of mortality and cancer incidence: the Multiethnic Cohort Study. Am J Epidemiol 2011;173:906-14. [PubMed abstract]
  37. Paranjpe MD, Chin AC, Paranjpe I, Reid NJ, Duy PQ, Wang JK, et al. Self-reported health without clinically measurable benefits among adult users of multivitamin and multimineral supplements: A cross-sectional study. BMJ Open 2020;10:e039119. [PubMed abstract]
  38. Loftfield E, O'Connell CP, Abnet CC, Graubard BI, Liao LM, et al. Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts. JAMA Netw Open. 2024 Jun 3;7(6):e2418729. [PubMed abstract]
  39. Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, et al. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2012;308:1751-60. [PubMed abstract]
  40. Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, et al. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2012;308:1871-80. [PubMed abstract]
  41. Grodstein F, O'Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, et al. Long-term multivitamin supplementation and cognitive function in men: A randomized trial. Ann Intern Med 2013;159:806-14. [PubMed abstract]
  42. Christen WG, Glynn RJ, Manson JE, MacFadyen J, Bubes V, Schwartz M, et al. Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians. Ophthalmology 2014;121:525-34. [PubMed abstract]
  43. Sesso HD, Rist PM, Aragaki AK, Rautiainen S, Johnson LG, Friedenberg G, et al. Multivitamins in the prevention of cancer and cardiovascular disease: The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr 2022;115:1501-10. [PubMed abstract]
  44. Baker LD, Manson JE, Rapp SR, Sesso HD, Gaussoin SA, Shumaker SA, et al. Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial. Alzheimer's & Dementia 2022;1-12. [PubMed abstract]
  45. Yeung LK, Alschuler DM, Wall M, Luttmann-Gibson H, Copeland T, et al. Multivitamin supplementation improves memory in older adults: A randomized clinical trial. Am J Clin Nutr. 2023 May 24:S0002-9165(23)48904-6. [PubMed abstract]
  46. Vyas CM, Manson JE, Sesso HD, Cook NR, Rist PM, Weinberg A, et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS. Am J Clin Nutr. 2024 Jan 18:S0002-9165(23)66342-7. [PubMed abstract]
  47. Li J-Y, Taylor PR, Li B, Dawsey S, Wang G-Q, Ershow AG, et al. Nutrition intervention trials in Linxian, China: Multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 1993;85:1492-8. [PubMed abstract]
  48. Wang J-B, Abnet CC, Fan J-H, Qiao Y-L, Taylor PR. The randomized Linxian dysplasia nutrition intervention trial after 26 years of follow-up: No effect of multivitamin supplementation on mortality. JAMA Intern Med 2013;173:1259-61. [PubMed abstract]
  49. Macpherson H, Pipingas A, Pase MP. Mutlvitamin-multimineral supplementation and mortality: A meta-analysis of randomized controlled trials. Am J Clin Nutr 2013;97:437-44. [PubMed abstract]
  50. Johnstone JM, Hughes A, Goldenberg JZ, Romijn AR, Rucklidge JJ. Multinutrients for the treatment of psychiatric symptoms in clinical samples: A systematic review and meta-analysis of randomized controlled trials. Nutrients 2020;12, 3394. [PubMed abstract]
  51. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42. [PubMed abstract]
  52. O'Connor EA, Evans CV, Ivlev I, Rushkin MC, Thomas RG, Martin A, Lin JS. Vitamin and mineral supplements for the primary prevention of cardiovascular disease and cancer. Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2022;327:2334-47. [PubMed abstract]
  53. US Preventive Services Task Force. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer. US Preventive Services Task Force recommendation statement. JAMA 2022;327:2326-33. [PubMed abstract]
  54. American Institute for Cancer Research. How to prevent cancer: 10 recommendationsexternal link disclaimer. Accessed July 12, 2022.
  55. American Heart Association. Multivitamins do not promote cardiovascular healthexternal link disclaimer. July 10, 2018.
  56. Centers for Disease Control. Recommendations: Women and folic acidexternal link disclaimer. 2021.
  57. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025external link disclaimer. 9th ed. December 2020.
  58. U.S. Preventive Services Task Force. Folic acid supplementation for the prevention of neural tube defects. U.S. Preventive Services Task Force recommendation statement. JAMA 2017;317:183-9. [PubMed abstract]
  59. American College of Obstetrics and Gynecologists. Nutrition during pregnancyexternal link disclaimer. March 2021.
  60. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experienceexternal link disclaimer. 2016.
  61. Wagner CL, Greer FR, and the Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142-52. [PubMed abstract]
  62. Institute of Medicine], Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2010.
  63. Marra MV, Bailey RL. Position of the Academy of Nutrition and Dietetics: Micronutrient supplementation. J Acad Nutr Diet 2018;118:2162-73. [PubMed abstract]
  64. Biesalski HK, Tinz J. Multivitamin/mineral supplements: Rationale and safety. Nutrition 2017;36:60-6. [PubMed abstract]
  65. Mulholland CA, Benford DJ. What is known about the safety of multivitamin-multimineral supplements for the generally healthy population? Theoretical basis for harm. Am J Clin Nutr 2007:85:318S-22S. [PubMed abstract]
  66. Prentice RL. Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements. Am J Clin Nutr 2007;85:308S-13S. [PubMed abstract]
  67. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers among male smokers. N Engl J Med 1994;330:1029-35. [PubMed abstract]
  68. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5. [PubMed abstract]
  69. Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zincexternal link disclaimer. Washington, DC: National Academy Press. 2001.
  70. Natural Medicines Comprehensive Database. Vitamin K. Accessed January 12, 2011.
  71. American Heart Association. A patient's guide to taking warfarinexternal link disclaimer, September 30, 2016.
  72. National Institutes of Health. Office of Dietary Supplements. Dietary Supplement Label Database. 2021.


This fact sheet by the National Institutes of Health (NIH) Office of Dietary Supplements (ODS) provides information that should not take the place of medical advice. We encourage you to talk to your health care providers (doctor, registered dietitian, pharmacist, etc.) about your interest in, questions about, or use of dietary supplements and what may be best for your overall health. Any mention in this publication of a specific product or service, or recommendation from an organization or professional society, does not represent an endorsement by ODS of that product, service, or expert advice.

Updated: July 17, 2024 History of changes to this fact sheet